; Online training course - Regulatory Affairs in the US
2021-12-08 2022-02-09 , Online Online, 1.090,- € plus tax Dr. Ulrich Granzer https://www.forum-institut.com/seminar/22022451-regulatory-affairs-in-the-us/referenten/22/22_02/22022451-online-training-course-pharma-regulatory-affairs-in-the-us_granzer-ulrich.jpg Regulatory Affairs in the US

Meet the expert Dr. Ulrich Granzer and get first-hand information, hints and tips for your daily business challenges with FDA approval of a medicine for the US market!

Topics
  • Drug regulation in the USA
  • The IND, NDA and BLA procedure
  • Communication with the FDA
  • Lifecycle: Post-approval changes and other maintenance duties
  • Interactive workshop session: You are invited to provide your individual cases prior to the event!
Aims and objectives
The purpose of this course is to provide an overview of the regulatory environment in the US.

After your participation you will
- be familiar with the requirements for FDA approval of a medicine for the US market
- have gained insight into the different development pathways
- know how to interact with the FDA
- understand the differences between the US vs. the EU approval process

Meet the expert Dr. Ulrich Granzer and get first-hand information, hints and tips for your daily business challenges!
Who should attend

This training course meets the needs of all those from the pharmaceutical industry who wish to develop their knowledge of the US regulatory environment including allied industries who wish to have a comprehensive understanding of the subject.

Online training course - Regulatory Affairs in the US

Regulatory Affairs in the US

- Online training -

Benefits
  • Meet the experts!
  • First-hand information
  • Experts with local know-how
  • Provide your individual questions beforehand
  • We are following the IMI quality criteria

Webcode 22022451

Book now

JETZT Buchen

Speakers


Everything at a glance

Appointment

08. - 09.02.2022

08. - 09.02.2022

Period

both days from 1:00 pm - 5:00 pm

both days from 1:00 pm - 5:00 pm
Venue

Online

Online

Fee
Ihr Ansprechpartner

Dr. Birgit Wessels
Conference Manager

+49 6221 500-652
b.wessels@forum-institut.de

Details

Meet the expert Dr. Ulrich Granzer and get first-hand information, hints and tips for your daily business challenges with FDA approval of a medicine for the US market!

Topics
  • Drug regulation in the USA
  • The IND, NDA and BLA procedure
  • Communication with the FDA
  • Lifecycle: Post-approval changes and other maintenance duties
  • Interactive workshop session: You are invited to provide your individual cases prior to the event!
Aims and objectives

The purpose of this course is to provide an overview of the regulatory environment in the US.

After your participation you will
- be familiar with the requirements for FDA approval of a medicine for the US market
- have gained insight into the different development pathways
- know how to interact with the FDA
- understand the differences between the US vs. the EU approval process

Meet the expert Dr. Ulrich Granzer and get first-hand information, hints and tips for your daily business challenges!

Who should attend

This training course meets the needs of all those from the pharmaceutical industry who wish to develop their knowledge of the US regulatory environment including allied industries who wish to have a comprehensive understanding of the subject.

Detailed programme

both days from 1:00 pm - 5:00 pm

13:00 Opening and introduction round


13:15

Drug regulation in the USA
  • Role, duties and responsibilities of the FDA: CBER, CDER, ...
  • FDARA, PDUFA VI, UFAs
  • Current developments

13:45

The IND (Investigational New Drug) procedure
  • Clinical trials in the US, mandatory?
  • Main aspects and differences for the compilation of IND and IMPD
  • Practical experiences
  • Avoiding typical mistakes

15:00 Coffee break


15:15

The NDA (New Drug Application) and BLA (Biological License Application) procedure
  • Dossier requirements
  • ANDA procedure
  • Drug master files
  • When NDA, when BLA?
  • Practical experiences
  • Avoiding typical mistakes

16:45 Summary and outstanding questions


17:00 End of training day I


13:00

Communication with the FDA
  • Meeting types: Pre-IND meeting, End of phase II, Pre-submission, Advisory committee meetings, ...
  • Planning and holding FDA meetings
  • Starting the communication: Meeting agenda

14:15 Coffee break


14:30

Workshop
You will work in small groups on one task, e.g. briefing book preparation, deficiency letter analysis or on your individual case. The results will be discussed in the plenum.

15:30

Marketing authorisation granted: The arising duties
  • Maintenance of INDs, NAD, BLA
  • Reporting obligations
  • Annual report
  • Dossier changes
  • Practical experiences
  • Avoiding typical mistakes

16:45 Summary and outstanding questions


17:00 End of training course


More information

Send us your individual questions

Please send us your questions concerning the seminar topics in advance.

We will be happy to forward them to the speakers, so that they know about your training requirements even better and are able to answer your questions at the seminar.

Please send your questions to b.wessels@forum-institut.de

How does an online seminar work?

Our online training courses are live and interactive. They are held and controlled directly by our speaker. You may take part in the seminar from anywhere using your end device. You will see the presentation and listen to our speaker's lecture using Internet telephony (VoIP) or even a normal telephone connection. And you can also ask questions live.

  • You will find brief instructions on how to use Zoom, your course documentation, the access link and a meeting ID in your personal customer account.
  • Use a headset, loudspeakers or the telephone for audio.
  • Listen to the speaker and follow the presentation.
  • Feel free to switch from silent to audio mode by yourself any time to ask your questions.

This distinguishes our events

Overall score of all evaluations in 2020

Five stars on Trustpilot = Excellent

Recommendations

PV audits & inspection strategies - Day 2: Pharmacovigilance Inspection Readiness

Our online course will provide insights into the current (remote) pharmacovigilance inspection strategy in Europe. Learn...

18.02.2022, Online
Details
PV audits & inspection strategies - Day 1: Risk based PV audits

Our experts will help you to identify risks in your PV system and will provide you with helpful methods to adjust your a...

17.02.2022, Online
Details

IDMP - what you need to do NOW

This workshop helps you collect, clean and structure all necessary data for IDMP and informs you on ePI (structured elec...

17.02.2022, Online
Details

PharmaFORUM Webcast International

Our global and local experts will update you every two months with the latest regulatory and legislative developments. T...

01.11. - 31.10.2023, Online
Details
The Pharmacovigilance System Master File (PSMF) in a Global Environment

This online-seminar will provide tips on how to prepare and maintain a core PSMF as well as annexes with the relevant lo...

17.02.2022, Online
Details

Go forward

Abkürzungsverzeichnis

In Regulatory Affairs gibt es viele Abkürzungen. Laden Sie sich hier die wichtigsten kostenfrei herunter.

Details
Glossar, Abkürzungen
DEMO-Account e-Learning

Try out our e-Learning programmes free of charge and without any obligation.

Details
DEMO-Account e-Learning
Quality guaranteed

Your feedback produced as result of 1.7 in 2020. Thank you!

Details
More on our quality criteria